Medindia LOGIN REGISTER
Medindia
Advertisement

Waters and Lambda Cooperate to Shape the Future of the Clinical Research Industry Worldwide

Tuesday, September 18, 2007 General News
Advertisement
MUMBAI, India, Sept. 17 Waters Corporation(NYSE: WAT) and Lambda Therapeutic Research Ltd. today announced a jointcooperative agreement that provides innovative analytical laboratory equipmentdesigned to enhance research quality service and business solutions for Lambdaand its clients.
Advertisement

The Agreement enables Lambda to meet its international business goals byfulfilling its needs for innovative laboratory equipment, including massspectrometry, liquid chromatography and laboratory software solutions.Additionally, Waters will share its keen understanding of scientific andlaboratory management through dedicated training opportunities.
Advertisement

"This agreement positions Lambda and our clients for international successon scientific and business levels," said AK Dasgupta, Director for LambdaTherapeutic Research. "Lambda's mission is to enhance research quality bycontinuously upgrading techniques and procedures that ensure scientificvalidity of all research projects. Key to this vision is aligning ourselveswith partners who understand our business and provide real solutions on ourservice and our business. Waters' product lines and strategic vision forlaboratory-driven companies makes them a perfect partner for Lambda."

The agreement paves the way for Lambda's adoption of several Watersproducts. Topping the list of solutions is the Waters Quattro Premier(TM) XEtandem quadrupole mass spectrometer paired with the ACQUITY UPLC(R) system andMassLynx(TM) software to address Lambda's need to analyze complex biologicalsamples. This Waters UPLC(R)/MS/MS system delivers a complete highly sensitiveplatform that is internationally regulatory compliant-ready for clinicallaboratories that require superior quantitative results and operationalefficiency.

"We recognize Lambda Therapeutic Research achievements as aninternationally world-class expert in clinical research," said Art Caputo,President of the Waters Division. "Through this Agreement, Waters seeks toshare our global understanding of laboratory analytics and provide innovativeproducts with Lambda to produce meaningful scientific and business impact. Weexpect this Agreement will reinforce and enhance Lambda's research leadershipboth in India and worldwide."

In addition to covering technology acquisition plans, Lambda and Watersidentified specific knowledge-sharing opportunities as well. Waters will hostLambda scientists at its training center in Manchester, England, and inviteinternationally-renowned analytical scientists to India for on-site Lambdascientific training. Lastly, Waters India will conduct mass spectrometry,liquid chromatography and sample preparation training at Lambda facilities.

About Lambda Therapeutic Research Ltd.

Lambda Therapeutic Research Ltd., India's largest clinical researchorganisation was established in 1999. Headquartered in Ahmedabad with aclinical facilities in Mumbai, Chennai & Warsaw, Poland Lambda established itscredentials as an innovative service provider offering clinical developmentsolutions to global pharmaceutical companies. Lambda partners with drugdevelopment programmes in several therapeutic areas, including oncology,gastrointestinal, cardiovascular, neurology, respiratory, autoimmunedeficiency, analgesics/inflammation and anti-infectives.

About Waters Corporation

Waters Corporation creates business advantage for laboratory-dependentorganizations by delivering practical and sustainable innovation to enablesignificant advancements in such areas as healthcare delivery, environmentalmanagement, food safety, and water quality worldwide.

Pioneering a connected portfolio of separations science, laboratoryinformation management, mass spectrometry and thermal analysis, Waterstechnology breakthroughs and laboratory solutions provide an enduring platformfor customer success.With revenue of $1.28 billion in 2006 and 4,700 emplo
Sponsored Post and Backlink Submission


Latest Press Release on General News

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close